PCMK
TEVA icon

Paragon Capital Management (Kansas)’s Teva Pharmaceuticals TEVA Stock Holding History

Paragon Capital Management (Kansas)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-299,538
Closed -$9.95M – 59
2017
Q2 		$9.95M Buy
299,538
+65,696
+28% +$2.03M 3.19% 17
2017
Q1 		$7.5M Buy
233,842
+74,938
+47% +$2.56M 2.35% 21
2016
Q4 		$5.76M Sell
158,904
-21,197
-12% -$846K 1.91% 26
2016
Q3 		$8.29M Buy
180,101
+17,867
+11% +$932K 2.8% 20
2016
Q2 		$8.15M Sell
162,234
-200
-0.1% -$10.6K 2.88% 19
2016
Q1 		$8.69M Buy
162,434
+1,222
+0.8% +$71.7K 3.39% 16
2015
Q4 		$10.6M Buy
161,212
+10,453
+7% +$646K 4.09% 8
2015
Q3 		$8.51M Sell
150,759
-9,581
-6% -$621K 3.31% 17
2015
Q2 		$9.48M Sell
160,340
-5,683
-3% -$351K 3.44% 14
2015
Q1 		$10.3M Buy
166,023
+469
+0.3% +$27.3K 3.86% 8
2014
Q4 		$9.52M Sell
165,554
-2,260
-1% -$126K 3.41% 13
2014
Q3 		$9.02M Sell
167,814
-965
-0.6% -$51.1K 3.46% 12
2014
Q2 		$8.85M Buy
168,779
+18,650
+12% +$953K 3.49% 8
2014
Q1 		$7.93M Sell
150,129
-2,535
-2% -$117K 3.4% 11
2013
Q4 		$6.12M Buy
152,664
+5,368
+4% +$211K 2.94% 19
2013
Q3 		$5.56M Buy
147,296
+46,440
+46% +$1.81M 2.85% 22
2013
Q2 		$3.95K Buy
+100,856
New +$3.93M 2.07% 25

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Paragon Capital Management (Kansas)'s TEVA Position: Q3 2017 in Review

Paragon Capital Management (Kansas) sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 299,538 shares — an estimated $9.95M sold.

Paragon Capital Management (Kansas) first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $10.6M in Q4 2015. 536 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Paragon Capital Management (Kansas) reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Paragon Capital Management (Kansas) sold 299,538 Teva Pharmaceuticals shares in Q3 2017, an estimated $9.95M.
  • Paragon Capital Management (Kansas) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Paragon Capital Management (Kansas)'s Teva Pharmaceuticals position peaked at $10.6M in Q4 2015.
  • 536 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q3 2017, filed 13 Nov 2017.